Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

OIG: Many FDAers Still Wary to Air Concerns, Unclear on Dispute Process

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Devices & Diagnostics Letter

The number of internal scientific disagreements over device approvals has waned since late 2009, when the FDA implemented new procedures for handling such disputes, but many employees are still hesitant…

Continue ReadingOIG: Many FDAers Still Wary to Air Concerns, Unclear on Dispute Process

House Subcommittee Sets Lower CDRH Funding for Fiscal 2013

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Devices & Diagnostics Letter/FDAnews Device Daily Bulletin

The House Appropriations Committee subcommittee that oversees FDA funding recommends fiscal 2013 appropriations that would slightly reduce agency spending. A full committee markup of the bill, as yet unnumbered, hasn’t…

Continue ReadingHouse Subcommittee Sets Lower CDRH Funding for Fiscal 2013

Indianapolis Helmet Maker Warned on Records, Procedural Flaws

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Devices & Diagnostics Letter

The FDA has cited a manufacturer of cranial remodeling helmets on seven areas of documentation and policy flaws.

Continue ReadingIndianapolis Helmet Maker Warned on Records, Procedural Flaws

Ethicon Asks FDA for 120 Days to Pull Vaginal Mesh From Market

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Devices & Diagnostics Letter

Johnson & Johnson’s (J&J) Ethicon unit will halt sales of some vaginal mesh products implicated in a class action lawsuit, but says it needs time to conduct the withdrawal properly.

Continue ReadingEthicon Asks FDA for 120 Days to Pull Vaginal Mesh From Market

Device Tax Repeal Passes House, Industry Takes Battle to Senate

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:Devices & Diagnostics Letter

Opponents of the medical device excise tax, mandated in the 2010 Affordable Care Act, are one step closer to repealing the contentious measure, after the House voted 270-146 to pass…

Continue ReadingDevice Tax Repeal Passes House, Industry Takes Battle to Senate
  • Go to the previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.